Provided by Tiger Trade Technology Pte. Ltd.

Werewolf Therapeutics, Inc.

0.6471
-0.4229-39.52%
Volume:5.31M
Turnover:3.36M
Market Cap:31.41M
PE:-0.40
High:0.8000
Open:0.7600
Low:0.5588
Close:1.07
52wk High:2.38
52wk Low:0.5588
Shares:48.54M
Float Shares:35.00M
Volume Ratio:23.80
T/O Rate:15.18%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.6177
EPS(LYR):-1.6273
ROE:-122.43%
ROA:-40.75%
PB:1.06
PE(LYR):-0.40

Loading ...

10% Owner Ansbert Gadicke Reports Sale of Werewolf Therapeutics Common Shares

Reuters
·
Nov 13

Werewolf Therapeutics Unveils Tumor-Selective INDUKINE Data at SITC 2025

Reuters
·
Nov 07

Director Luke Evnin Reports Disposal of Werewolf Therapeutics Inc. Common Shares

Reuters
·
Nov 07

MPM BioVentures 2014, L.P. Reports Disposal of Werewolf Therapeutics Inc. Common Shares

Reuters
·
Nov 07

10% Owner Ansbert Gadicke Reports Sale of Werewolf Therapeutics Inc. Common Shares

Reuters
·
Nov 07

Wedbush Halves Price Target on Werewolf Therapeutics to $3 From $6, Keeps Outperform Rating

MT Newswires Live
·
Nov 05

Werewolf Therapeutics reports Q3 EPS (36c), consensus (38c)

TIPRANKS
·
Nov 04

Werewolf Therapeutics Q3 EPS $(0.36) Beats $(0.39) Estimate

Benzinga
·
Nov 04

Werewolf Therapeutics Reports Q3 2025 Results and Plans Key Trial Updates

Reuters
·
Nov 04

MPM BioVentures 2014, L.P. Reports Disposal of Werewolf Therapeutics Common Shares

Reuters
·
Nov 04

10% Owner Ansbert Gadicke Reports Disposal of Werewolf Therapeutics Inc. Common Shares

Reuters
·
Nov 04

Werewolf Therapeutics Inc expected to post a loss of 39 cents a share - Earnings Preview

Reuters
·
Oct 31

Director Luke Evnin Reports Disposal of Werewolf Therapeutics Inc. Common Shares

Reuters
·
Oct 30

MPM BioVentures 2014, L.P. Reports Disposal of Werewolf Therapeutics Inc. Common Shares

Reuters
·
Oct 30

Werewolf Therapeutics’ Promising Study on WTX-124 in Cancer Treatment

TIPRANKS
·
Oct 28

BUZZ-U.S. STOCKS ON THE MOVE-Datadog, First Majestic, Best Buy

Reuters
·
Oct 09

Werewolf Therapeutics Shares up 4% After Co Receives FDA's 'Fast Track' Tag for Cancer Therapy

THOMSON REUTERS
·
Oct 08

BUZZ-U.S. STOCKS ON THE MOVE-Ford Motor, CVS Health, Phillips 66

Reuters
·
Oct 08

Werewolf Therapeutics Receives FDA Fast Track Designation for WTX124 in Advanced Melanoma

Reuters
·
Oct 08

Werewolf Therapeutics Receives Fast Track Designation From the U.S. FDA for Wtx-124, an Investigational Therapy for the Treatment of Cancer

THOMSON REUTERS
·
Oct 08